According to expert recommendations, statins should be the first treatment chosen but by the results of research there is the possibility that other interventions may offer the same clinical advantage.
Data from 49 trials including 312,175 patients indicate that non-statin treatments that lower cholesterol are as beneficial as statins in decreasing risk of heart attack.
According to a large meta-analysis the comparative benefits of non-statin cholesterol-lowering treatments comprising diet, have similar benefits to statins in decreasing the risk of heart attack and stroke.
Researchers found by data from 49 trials involving 312,175 patients covering nine different options for lowering low-density lipoprotein cholesterol (LDL-C) that the use of statin and non-statin therapies have similar risks of major vascular events.
Date: 28th September 2016